Genetic Testing Could Greatly Benefit Patients with Depression
A special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MorePosted by Andy Lundin | Nov 14, 2023 | Molecular Diagnostics |
A special kind of genetic testing that determines the best antidepressant for patients with depression may greatly improve patient outcomes.
Read MorePosted by Andy Lundin | Nov 9, 2023 | Diagnostic Technologies, Disease States |
Roche’s Elecsys NfL test for MS received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Nov 6, 2023 | Cervical (HPV), Molecular Diagnostic Analyzers |
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cancer |
The TruSightf Oncology 500 ctDNA v2 enables comprehensive genomic profiling of ctDNA from blood when tissue testing is not available.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cervical (HPV), Molecular Diagnostics |
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read More